Carlyle Offers J&J $4.15 Billion for Testing Unit

If the deal goes through, Carlyl plans to run Johnson & Johnson's Ortho-Clinical Diagnostics medical testing unit as an independent company. If the deal goes through, Carlyl plans to run Johnson & Johnson's Ortho-Clinical Diagnostics medical testing unit as an independent company. read more
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.